# Diabetes Mellitus, Type 1 trials: 430 new since Nov 2024

Updated November 9, 2026.

430 clinical studies in Diabetes Mellitus, Type 1 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 88 have an industry sponsor and 297 are recruiting or about to. The newest, NCT07924553, was posted on November 9, 2026: Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes (Peking University People's Hospital).

## The full list

New Diabetes Mellitus, Type 1 clinical trials: 430 rows for $21.50, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 17 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-1

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 430
- Industry sponsored: 88
- Recruiting or not yet: 297
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 430, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07924553 | Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes | Peking University People's Hospital | Not applicable | Not yet recruiting | Type 1 Diabetes | 182 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924553) |
| November 5, 2026 | NCT07920341 | Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes | University of the Pacific | Not applicable | Not yet recruiting | Continuous Glucose Monitoring, Type 1 Diabetes, Type 2 Diabetes | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920341) |
| November 3, 2026 | NCT07914621 | Outpatient Pramlintide Study | Oregon Health and Science University | Not applicable | Not yet recruiting | Type 1 Diabetes | 26 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914621) |
| November 2, 2026 | NCT07911033 | Relationship Between Insulin Dose and Complications in Type 1 Diabetes | Rachel Miller | Observational | Not yet recruiting | Diabetes Mellitus, Type 1 Diabetes, Cardiovascular Diseases (CVD), Severe Albuminuria, Estimated Glomerular Filtration... | 80 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911033) |
| November 2, 2026 | NCT07911007 | Differentiating Heart Disease Between Adult-onset Autoimmune and Type 2 Diabetes | University of Roma La Sapienza | Not applicable | Recruiting | Diabete Mellitus, Autoimmune Diabetes, Latent Autoimmune Diabetes in Adult (LADA), Type 2 Diabetes, Heart Disease... | 200 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911007) |
| October 28, 2026 | NCT07901595 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2... | Paulex Bio Inc. | Phase 1/2 | Not yet recruiting | Healthy Volunteers and Diabetes Participants | 147 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901595) |
| October 23, 2026 | NCT07892651 | MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) | Axiom Bioregistry | Observational | Not yet recruiting | Antiphospholipid (aPL)-Positive, Rheumatic Arthritis, Celiac Disease, Focal Segmental Glomerulosclerosis (FSGS)... | 5,000 | Jordan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892651) |
| October 23, 2026 | NCT07891156 | Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity. | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2/3 | Recruiting | Type 1 Diabetes, Overweight , Obesity | 40 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891156) |
| October 22, 2026 | NCT07889505 | A Phase 2 Two-Part Study of Oral PS1 in Healthy Volunteers and Adults With Newly Diagnosed Type 1 Diabetes | Pharmasaga Co. Ltd. | Phase 2 | Not yet recruiting | Type 1 Diabetes Mellitus | 36 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889505) |
| October 22, 2026 | NCT07889388 | RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study | Bionime Corporation | Not applicable | Recruiting | Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 2, Diabetes, Gestational | 104 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889388) |
| October 21, 2026 | NCT07886307 | Comprehensive Intervention to Promote Adjustment in Adolescents With Type 1 Diabetes and Their Parents During Transfer of Health Care... | Universidad de la Sabana | Not applicable | Completed | Type 1 Diabetes Mellitus (T1DM), Parent, Adolescent, Nursing | 34 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886307) |
| October 19, 2026 | NCT07880769 | Verapamil In Preclinical Type 1 Diabetes | Assistance Publique - Hôpitaux de Paris | Phase 2/3 | Not yet recruiting | Type 1 Diabetes | 50 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880769) |
| October 14, 2026 | NCT07872800 | Pancreas Transplant Alone in Uremia and Non-uremia Patients | Taipei Veterans General Hospital, Taiwan | Observational | Completed | Pancreas Transplant, Type 1 Diabetes Mellitus, Uremia | 184 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872800) |
| October 13, 2026 | NCT07872475 | Randomized Transition to Gla-300 in Pediatric Type 1 Diabetes: CGM-Derived Outcomes | Marmara University | Phase 4 | Completed | Type 1 Diabetes Mellitus | 71 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872475) |
| October 8, 2026 | NCT07865923 | Clinical Trial for the Study of Stress and Exercise Impact on Glucose Levels and Additional Physiological Signals. Stress, Insulin and... | National Council of Scientific and Technical Research, Argentina | Not applicable | Completed | Type 1 Diabetes (T1D) | 5 | Argentina | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865923) |
| October 7, 2026 | NCT07864168 | Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes | Medtronic MiniMed, Inc. | Not applicable | Recruiting | Type 1 Diabetes, Type 2 Diabetes | 1,500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864168) |
| October 6, 2026 | NCT07861373 | DiaBuddy: AI-Enabled Digital Self-Management for Youth With Type 1 Diabetes | Dr. Juwayria Omar | Not applicable | Not yet recruiting | Type 1 Diabetes Mellitus, Diabetes Self-Management Education, Caregiver Burden | 140 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861373) |
| October 6, 2026 | NCT07860229 | Food Prescription Among Youth With Type 1 Diabetes | Baylor College of Medicine | Not applicable | Not yet recruiting | Type 1 Diabetes (T1D) | 45 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860229) |
| October 6, 2026 | NCT07859943 | Inspiratory Muscle Strength Training in Adults With Type 1 Diabetes | Florida State University | Not applicable | Not yet recruiting | Type 1 Diabetes | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859943) |
| October 5, 2026 | NCT07856836 | Insul-In This Together: Leveraging Family Support and Diabetes Technology for Adolescents Living With Type 1 Diabetes | Stanford University | Not applicable | Not yet recruiting | Diabetes Type 1 | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856836) |
| October 1, 2026 | NCT07851662 | Functional Mobility and Resistance Exercise for Postmenopausal Females With Type 1 Diabetes | Institut de Recherches Cliniques de Montreal | Not applicable | Not yet recruiting | Type 1 Diabetes (T1D), Menopause | 63 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851662) |
| September 29, 2026 | NCT07846852 | Impact of Dietary Intervention Within an Interprofessional Cooperative Protocol for Prandial Insulin Dose Adjustment in People Living With... | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Diabetes Mellitus, Type 1 | 163 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846852) |
| September 29, 2026 | NCT07845955 | JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D | Huijie Zhang | Phase 2 | Not yet recruiting | T1DM - Type 1 Diabetes Mellitus | 132 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845955) |
| September 28, 2026 | NCT07845175 | Gastrointestinal Symptoms in Children With Type 1 Diabetes | Assiut University | Observational | Not yet recruiting | Type 1 Diabetes Mellitus | 254 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845175) |
| September 23, 2026 | NCT07835724 | Environmental Determinants of Type 1 Diabetes Risk | Second Xiangya Hospital of Central South University | Observational | Recruiting | Type 1 Diabetes Mellitus (T1DM), Healthy Control, Relatives to/Carers of Patients | 11,240 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835724) |
| September 23, 2026 | NCT07835685 | Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With... | mylife Diabetes Care AG | Observational | Not yet recruiting | Diabetes Type 1 | 220 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835685) |
| September 22, 2026 | NCT07834801 | Structured Carbohydrate-Counting Education in Adults With Type 1 Diabetes | Acibadem University | Not applicable | Completed | Type 1 Diabetes Mellitus | 38 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834801) |
| September 22, 2026 | NCT07833865 | The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic Patients | University of Thi-Qar | Not applicable | Not yet recruiting | Healthy, Diabetes Mellitus Type 1 | 30 | Iraq | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833865) |
| September 21, 2026 | NCT07831798 | VV-14300 for the Treatment of Type 1 Diabetes | Kriya Therapeutics, Inc. | Phase 1/2 | Recruiting | Type 1 Diabetes Mellitus | 29 | Canada, New Zealand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831798) |
| September 21, 2026 | NCT07830082 | Drawing and Writing Activities in Adolescents With Type 1 Diabetes | Gazi University | Not applicable | Recruiting | Type 1 Diabetes Mellitus (T1DM), Anxiety | 50 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830082) |
| September 21, 2026 | NCT07829302 | VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes | Kriya Therapeutics, Inc. | Phase 1/2 | Recruiting | Type 1 Diabetes Mellitus | 29 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829302) |
| September 18, 2026 | NCT07828626 | Benefits of Retained Insulin for Good Health | Royal Devon and Exeter NHS Foundation Trust | Observational | Recruiting | Diabetes (Insulin-requiring, Type 1 or Type 2), Diabetes, Diabetes (DM), Type 1 Diabetes (T1D) | 700 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828626) |
| September 18, 2026 | NCT07828106 | Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1... | Sheba Medical Center | Not applicable | Recruiting | Diabetes Mellitus, Type 1 Diabetes, Mobile Health Platform, Mobile Health Technology (mHealth), Mobile Health... | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828106) |
| September 11, 2026 | NCT07814508 | Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App | FIDAM RDC | Not applicable | Recruiting | Diabetes (DM), Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus Type 1, Diabetes Mellitus ( Type 1 and... | 89 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814508) |
| September 10, 2026 | NCT07812974 | Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation | University Hospital, Strasbourg, France | Observational | Not yet recruiting | Type 1 Diabetes (T1D) | 25 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812974) |
| September 8, 2026 | NCT07808385 | Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1... | Mayo Clinic | Not applicable | Not yet recruiting | Type 1 Diabetes, Pregnancy | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808385) |
| September 8, 2026 | NCT07807553 | Liver Function Test Abnormalities in Pediatric Type 1 Diabetes | Assiut University | Observational | Not yet recruiting | Diabetes Mellitus, Type 1, Liver Diseases | 101 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807553) |
| September 8, 2026 | NCT07807280 | C-Carbs: A CGM-guided Approach to Teaching Carb Awareness | University of California, Los Angeles | Not applicable | Recruiting | Type 1 Diabetes | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07807280) |
| September 4, 2026 | NCT07804849 | Oral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 Diabetes | Ain Shams University | Phase 2/3 | Recruiting | Type 1 Diabetes Mellitus | 70 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804849) |
| September 4, 2026 | NCT07803744 | A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity | Eli Lilly and Company | Phase 1 | Recruiting | Diabetes Mellitus, Type 1, Overweight, Obesity | 18 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803744) |
| September 3, 2026 | NCT07802496 | Genetically Informed Screening for Early-Stage Type 1 Diabetes | Massachusetts General Hospital | Observational | Not yet recruiting | Diabetes | 150 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802496) |
| August 28, 2026 | NCT07793097 | Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes? | Wayne State University | Not applicable | Not yet recruiting | Type 1 Diabetes | 48 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793097) |
| August 26, 2026 | NCT07787754 | The Effect of Sea Buckthorn Extract in Patients With Type 1 Diabetes | The First Affiliated Hospital of Guangzhou Medical University | Not applicable | Completed | Type 1 Diabetes | 30 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787754) |
| August 25, 2026 | NCT07786064 | Comparative Study of the Postprandial Glycemic Profile After Consumption of a High-fat Meal (Pizza) Between the Open-loop System (Medtronic... | Konstantinos Makrilakis, MD | Not applicable | Completed | Type 1 Diabetes Mellitus | 20 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786064) |
| August 25, 2026 | NCT07785037 | Omnipod 5 Implementation in Belgian Paediatric Diabetes Care | Queen Fabiola Children's University Hospital | Observational | Not yet recruiting | Type 1 Diabetes Mellitus | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785037) |
| August 21, 2026 | NCT07780487 | Phipps Conservatory's 5210 Let's Move Pittsburgh and Impact on Youth With T1D | University of Pittsburgh | Not applicable | Completed | Type 1 Diabetes Mellitus | 46 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780487) |
| August 21, 2026 | NCT07778147 | Effects of Bedtime Snack Composition on Overnight Glucose in Children and Adolescents With Type 1 Diabetes | Didem Güneş Kaya | Not applicable | Completed | Type 1 Diabetes (T1D) | 20 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778147) |
| August 19, 2026 | NCT07774780 | Oral Galactose as a Substrate for Post-Exercise Skeletal Muscle Glycogen Repletion in Individuals With Type 1 Diabetes | University of Aarhus | Not applicable | Not yet recruiting | Type 1 Diabetes | 16 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07774780) |
| August 19, 2026 | NCT07773779 | APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life | Weill Medical College of Cornell University | Not applicable | Recruiting | Diabetes (Insulin-requiring, Type 1 or Type 2) | 52 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773779) |
| August 17, 2026 | NCT07769138 | Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM) | Imperial College Healthcare NHS Trust | Observational | Not yet recruiting | Type 1 Diabetes, Type 2 Diabetes Treated With Insulin, Hyperglycemia, Intensive Care (ICU), Continuous Glucose... | 70 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769138) |
| August 17, 2026 | NCT07767461 | Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and... | Steno Diabetes Center Copenhagen | Not applicable | Recruiting | Contact Dermatitis, Type 1 Diabetes Mellitus | 30 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07767461) |
| August 17, 2026 | NCT07766811 | Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching | Nemours Children's Clinic | Not applicable | Recruiting | Implementation Science, Type 1 Diabetes in Adolescence, Implementation Strategies | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766811) |
| August 11, 2026 | NCT07758647 | NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems | Institut de Recherches Cliniques de Montreal | Not applicable | Not yet recruiting | Type 1 Diabetes (T1D) | 33 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758647) |
| August 6, 2026 | NCT07750210 | Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes | Sohag University | Observational | Not yet recruiting | MASLD, Type 1 Diabetes | 250 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750210) |
| August 4, 2026 | NCT07745998 | The BRIGHT Study (Device Name: HALO System) | Indigo Diabetes NV | Not applicable | Not yet recruiting | Diabetes Mellitus - Type 1, Diabetes Mellitus - Type 2, Diabetes Mellitus, Ketoacidosis, Diabetic, Hyperglycaemia... | 12 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745998) |
| August 3, 2026 | NCT07742306 | Continuous Glucose Monitoring in High-Risk Children and Youth With Type 1 Diabetes in the Dominican Republic | Life for a Child Program, Diabetes Australia | Observational | Recruiting | Type 1 Diabetes (T1D) | 40 | Dominican Republic | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742306) |
| July 31, 2026 | NCT07739342 | Evaluating the Occurrence of DKA in People With Type I Diabetes | Abbott Diabetes Care | Observational | Not yet recruiting | Type 1 Diabetes | 1,200 | New Zealand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739342) |
| July 29, 2026 | NCT07732777 | AI-Assisted Remote Insulin Pump Optimization in T1DM | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Not applicable | Recruiting | Type 1 Diabetes Mellitus, Type 1 Diabetes (T1D) | 50 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732777) |
| July 24, 2026 | NCT07726680 | GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes | Shifa International Hospital | Not applicable | Recruiting | Type 1 Diabetes Mellitus (T1DM), Diabetes Distress, Hypoglycemia (Diabetic), Family Conflict | 110 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07726680) |
| July 22, 2026 | NCT07720388 | Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative | University of Colorado, Denver | Not applicable | Recruiting | Diabetes Mellitus, Type 1 Diabetes | 15 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720388) |
| July 20, 2026 | NCT07712809 | Intelligent Care Platform - Quasi-Experimental Trial | University of British Columbia | Not applicable | Enrolling by invitation | Diabetes in Children, Diabetes Type 1 | 80 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712809) |
| July 17, 2026 | NCT07711275 | Hypoglycemia Thresholds in Type 1 Diabetes | Marmara University | Not applicable | Completed | Diabetes Mellitus, Type 1 | 33 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711275) |
| July 16, 2026 | NCT07706803 | Screening For Social Determinants Of Health In Routine Diabetes Care | University of California, Los Angeles | Not applicable | Not yet recruiting | Type 1 Diabetes | 150 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706803) |
| July 15, 2026 | NCT07705321 | Assessment of Retinal Microcirculation in Patients With Type 1 Diabetes Mellitus | University of Athens | Observational | Active not recruiting | Diabetes Type 1, Diabetic Retinopathy, Microvascular Circulation, Retinal Microvascular Disease, Diabetic Complications | 100 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705321) |
| July 13, 2026 | NCT07699380 | METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Phase 2 | Recruiting | Type 1 Diabetes (T1D), Metabolic Diseases, Glucose Metabolism Disorders, Endocrine System Diseases, Autoimmune... | 60 | Netherlands, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07699380) |
| July 10, 2026 | NCT07696780 | Diabetes Management Among Women Using an AID System: a Mixed Method Study | DCB Research AG | Observational | Completed | Type 1 Diabetes | 69 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696780) |
| July 10, 2026 | NCT07696039 | Real-world Effectiveness and Safety of Omnipod 5 in Adults With Type 1 Diabetes: a 12-month Observational Study. | Papa Giovanni XXIII Hospital | Observational | Completed | Type 1 Diabetes Mellitus | 300 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696039) |
| July 10, 2026 | NCT07695727 | Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes | IRCCS San Raffaele | Observational | Not yet recruiting | Type 1 Diabetes, Autoimmunity | 84 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695727) |
| July 8, 2026 | NCT07689318 | Effect of a Structured Educational Intervention Through Mobile App on Hemoglobin A1c (HbA1c), Self-Efficacy and Self- Care in Adolescent... | Shifa Tameer-e-Millat University | Not applicable | Not yet recruiting | Type 1 Diabetes (Juvenile Onset), Type 1 Diabetes, Type 1 Diabetes Mellitus, HbA1c, HbA1c Level, Self Care, Self... | 84 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689318) |
| July 6, 2026 | NCT07684248 | Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Not applicable | Not yet recruiting | Type 1 Diabetes | 200 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684248) |
| July 6, 2026 | NCT07683026 | Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | Not yet recruiting | Type 1 Diabetes (T1D) | 255 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07683026) |
| July 2, 2026 | NCT07680673 | ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and... | Encellin | Phase 1 | Not yet recruiting | Type 1 Diabetes | 10 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680673) |
| July 1, 2026 | NCT07679347 | Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection | SAVA Technologies Ltd. | Not applicable | Not yet recruiting | Type 1 Diabetes Mellitus | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679347) |
| June 30, 2026 | NCT07676565 | Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study | Indiana University | Observational | Recruiting | Type 1 Diabetes | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676565) |
| June 30, 2026 | NCT07675590 | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects | TIXiMED, Inc. | Phase 1 | Recruiting | Health Adult Subjects, Obesity & Overweight | 18 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675590) |
| June 29, 2026 | NCT07673523 | Effect of Dietary Carbohydrate Content and Inulin-Fructooligosaccharide Supplementation on Glycemic Control in Individuals With Type 1... | Hacettepe University | Not applicable | Active not recruiting | Type 1 Diabetes Mellitus | 30 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673523) |
| June 26, 2026 | NCT07671053 | Feasibility and Effectiveness of an AI-Powered Carbohydrate Counting Educational Platform to Support Parents of Children With Type 1... | Sultan Qaboos University | Not applicable | Not yet recruiting | Type 1 Diabetes Mellitus | 80 | Oman, United Arab Emirates | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671053) |
| June 26, 2026 | NCT07670650 | PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1... | University of Florida | Phase 3 | Not yet recruiting | Type 1 Diabetes (T1D) | 108 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670650) |
| June 26, 2026 | NCT07670572 | Think-Find-Solve Activities for Insulin Self-Management in Type 1 Diabetes | Marmara University | Not applicable | Recruiting | Type 1 Diabetes, Children, Activity, Insulin, Self Management, Parent | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670572) |
| June 26, 2026 | NCT07670143 | M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials | IRCCS San Raffaele | Observational | Not yet recruiting | Type 1 Diabetes | 50,000 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670143) |
| June 25, 2026 | NCT07667504 | Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Not applicable | Recruiting | Type 1 Diabetes (T1D), Obesity & Overweight | 75 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667504) |
| June 24, 2026 | NCT07666789 | Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement | University Hospital, Montpellier | Observational | Recruiting | Type 1 Diabetes (T1D), Islets of Langerhans Transplantation | 20 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07666789) |
| June 23, 2026 | NCT07663136 | Finding Immune Nascent Type 1 Diabetes | Indiana University | Not applicable | Recruiting | Healthy Adult, Type 1 Diabetes (T1D) | 3,800 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07663136) |
| June 17, 2026 | NCT07655076 | Simultaneous Measurement and Responsive Treatment - Part 2 | ClinSurge Research | Early phase 1 | Recruiting | Type 1 Diabetes Mellitus, T1D, Type 1 Diabetes, T1DM | 40 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07655076) |
| June 16, 2026 | NCT07650682 | Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes | Clinical Nutrition Research Center, Illinois Institute of Technology | Observational | Recruiting | Type 2 Diabetes, Insulin Dependent Diabetes | 25 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650682) |
| June 12, 2026 | NCT07646067 | Closed Loop Glucose Control in a Simulated ICU Setting | Ideal Medical Technologies | Not applicable | Not yet recruiting | Type 1 Diabetes, Type 2 Diabetes, Stress Induced Hyperglycemia | 6 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646067) |
| June 12, 2026 | NCT07645313 | Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With Diabetes | Yuwell Group | Not applicable | Not yet recruiting | Diabetes Mellitus, Type 1 \| Diabetes Mellitus, Type 2 | 70 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645313) |
| June 10, 2026 | NCT07638345 | DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic... | Adhera Health, Inc. | Not applicable | Recruiting | Type 1 Diabetes, T1D, Obesity & Overweight, Obesity Type 2 Diabetes Mellitus, Asthma Acute, Asthma (Diagnosis) | 280 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638345) |
| June 9, 2026 | NCT07634770 | Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin | Sam Chun Dang Pharm. Co. Ltd. | Phase 1 | Recruiting | Diabetes Mellitus, Type 1 | 16 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07634770) |
| June 4, 2026 | NCT07627230 | Biomarkers of Type 1 Diabetes in Children and Their Healthy Siblings | Privolzhsky Research Medical University | Observational | Completed | Type 1 Diabetes Mellitus | 1,034 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627230) |
| June 2, 2026 | NCT07621445 | Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter... | Second Xiangya Hospital of Central South University | Observational | Recruiting | Diabetes Mellitus, Diabetes Mellitus, Type 1 | 2,950 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621445) |
| June 1, 2026 | NCT07617519 | Changing Outpatient Diabetes Care With Remote-Patient-Monitoring: A Real World Evidence Study With Pre-Post Comparison | Steno Diabetes Center Copenhagen | Observational | Recruiting | Diabetes, Diabetes Care, Diabetes Type 1, Diabetes Type 2, Remote Patient Monitoring, Digital Health | 12,000 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617519) |
| June 1, 2026 | NCT07616206 | Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems | vTv Therapeutics | Phase 2 | Not yet recruiting | Type 1 Diabetes (T1D) | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616206) |
| May 29, 2026 | NCT07614412 | SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes. | Ministry of Health, Saudi Arabia | Phase 2 | Not yet recruiting | Type 1 Diabetes Mellitus | 240 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614412) |
| May 28, 2026 | NCT07612475 | Universal Type 1 Diabetes Screening in Pediatrics | Northwestern University | Observational | Enrolling by invitation | Type 1 Diabetes (T1D) | 9,500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612475) |
| May 27, 2026 | NCT07610213 | Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes | Abdullah Kars | Phase 1 | Not yet recruiting | Type 1 Diabetes Mellitus (T1DM), Type 1 Diabetes Mellitus, Autoimmune Diabetes | 60 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610213) |
| May 20, 2026 | NCT07599982 | Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes | DreaMed Diabetes | Not applicable | Recruiting | Type 1 Diabetes (T1D), Type 2 Diabetes (T2D) | 102 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599982) |
| May 19, 2026 | NCT07596160 | Individualized Exercise Consultation in Type 1 Diabetes | University of Aarhus | Not applicable | Not yet recruiting | Type 1 Diabetes | 60 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596160) |
| May 18, 2026 | NCT07594145 | Precision T1D Platform - New Therapies for Cardio-Renal Complications | Oregon Health and Science University | Phase 2 | Not yet recruiting | Type 1 Diabetes, T1D Heart Failure, Cardio-renal Vascular Function and Failure, Diabetic Chronic Kidney Disease | 57 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594145) |
| May 18, 2026 | NCT07593625 | Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D | Insulet Corporation | Not applicable | Recruiting | Type 1 Diabetes, Type 1 Diabetes Mellitus, Diabetes (DM) | 80 | New Zealand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593625) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Novo Nordisk A/S | 9 | May 11, 2026 |
| Sanofi | 8 | March 9, 2026 |
| Institut de Recherches Cliniques de Montreal | 6 | October 1, 2026 |
| Ain Shams University | 6 | September 4, 2026 |
| Eli Lilly and Company | 6 | September 4, 2026 |
| Medtronic MiniMed, Inc. | 5 | October 7, 2026 |
| Stanford University | 5 | October 5, 2026 |
| Second Xiangya Hospital of Central South University | 5 | September 23, 2026 |
| University of Aarhus | 5 | August 19, 2026 |
| Steno Diabetes Center Copenhagen | 5 | August 17, 2026 |
| Assiut University | 4 | September 28, 2026 |
| Sohag University | 4 | August 6, 2026 |
| Insulet Corporation | 4 | May 18, 2026 |
| Sue Brown | 4 | April 8, 2026 |
| Tandem Diabetes Care, Inc. | 4 | January 8, 2026 |
| Yale University | 4 | September 4, 2025 |
| Oregon Health and Science University | 3 | November 3, 2026 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 | October 23, 2026 |
| Marmara University | 3 | October 13, 2026 |
| Mayo Clinic | 3 | September 8, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 218 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 124 | November 2, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 27 | October 22, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 17 | September 4, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 14 | June 26, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 10 | October 28, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 8 | October 23, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 6 | October 13, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 6 | June 17, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 123 | November 5, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 32 | October 19, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 31 | July 6, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 27 | November 2, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 26 | October 23, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 23 | October 22, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 22 | September 29, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 21 | October 13, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 20 | August 19, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 18 | September 18, 2026 |
| [Israel](https://specstream.ai/data/clinical-trials/country/israel) | 13 | September 18, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 13 | September 4, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 13 | April 3, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 10 | September 21, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 10 | August 25, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 10 | July 13, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 10 | October 29, 2025 |
| [Czechia](https://specstream.ai/data/clinical-trials/country/czechia) | 8 | January 29, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 8 | December 10, 2025 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 7 | March 9, 2026 |
| [New Zealand](https://specstream.ai/data/clinical-trials/country/new-zealand) | 6 | September 21, 2026 |
| [Saudi Arabia](https://specstream.ai/data/clinical-trials/country/saudi-arabia) | 6 | May 29, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 6 | October 29, 2025 |
| [Argentina](https://specstream.ai/data/clinical-trials/country/argentina) | 5 | October 8, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 5 | July 10, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).